Evommune, Inc.

EVMN

—

Advanced chart & tools →

Evommune, Inc.EVMN

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-11.22

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$13.00M

Net income

$-68.87M

Net margin

-529.8%

Gross margin

—

Dividends & financials

Evommune, Inc. (EVMN) reported revenue of $13.00M and net income of $-68.87M, or $-11.22 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.